Search by Drug Name or NDC

    NDC 49967-0997-01 Cerave Developed with Dermatologists Hydrating Sunscreen SPF 30 Body Lightweight, non-greasy feel 3 essential ceramides Mineral Sunscreen 60; 50 mg/mL; mg/mL Details

    Cerave Developed with Dermatologists Hydrating Sunscreen SPF 30 Body Lightweight, non-greasy feel 3 essential ceramides Mineral Sunscreen 60; 50 mg/mL; mg/mL

    Cerave Developed with Dermatologists Hydrating Sunscreen SPF 30 Body Lightweight, non-greasy feel 3 essential ceramides Mineral Sunscreen is a TOPICAL LOTION in the HUMAN OTC DRUG category. It is labeled and distributed by L'Oreal USA Products Inc. The primary component is TITANIUM DIOXIDE; ZINC OXIDE.

    Product Information

    NDC 49967-0997
    Product ID 49967-997_8e86ac73-ca71-461d-be92-211850273f5f
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Cerave Developed with Dermatologists Hydrating Sunscreen SPF 30 Body Lightweight, non-greasy feel 3 essential ceramides Mineral Sunscreen
    Proprietary Name Suffix n/a
    Non-Proprietary Name Titanium dioxide and Zinc oxide
    Product Type HUMAN OTC DRUG
    Dosage Form LOTION
    Route TOPICAL
    Active Ingredient Strength 60; 50
    Active Ingredient Units mg/mL; mg/mL
    Substance Name TITANIUM DIOXIDE; ZINC OXIDE
    Labeler Name L'Oreal USA Products Inc
    Pharmaceutical Class Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part352
    Listing Certified Through 2024-12-31

    Package

    NDC 49967-0997-01 (49967099701)

    NDC Package Code 49967-997-01
    Billing NDC 49967099701
    Package 1 TUBE in 1 CARTON (49967-997-01) / 150 mL in 1 TUBE
    Marketing Start Date 2019-02-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 669e8150-7e14-4572-9784-319a302b8aa1 Details

    Revised: 12/2018